tradingkey.logo

Artivion Inc

AORT
46.600USD
-0.550-1.17%
Close 12/19, 16:00ETQuotes delayed by 15 min
2.21BMarket Cap
LossP/E TTM

Artivion Inc

46.600
-0.550-1.17%

More Details of Artivion Inc Company

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.

Artivion Inc Info

Ticker SymbolAORT
Company nameArtivion Inc
IPO dateFeb 12, 1993
CEOMackin (James Patrick)
Number of employees1600
Security typeOrdinary Share
Fiscal year-endFeb 12
Address1655 Roberts Boulevard N W
CityKENNESAW
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code30144
Phone17704193355
Websitehttps://artivion.com/
Ticker SymbolAORT
IPO dateFeb 12, 1993
CEOMackin (James Patrick)

Company Executives of Artivion Inc

Name
Name/Position
Position
Shareholding
Change
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
178.56K
-5.27%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
+4.40%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
+4.41%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
+5.12%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
125.79K
-4.06%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
121.36K
+10.09%
Mr. James W. Bullock
Mr. James W. Bullock
Independent Director
Independent Director
68.65K
+10.15%
Mr. Jeffrey H. (Jeff) Burbank
Mr. Jeffrey H. (Jeff) Burbank
Lead Independent Director
Lead Independent Director
53.80K
+13.32%
Mr. Matthew A. (Matt) Getz
Mr. Matthew A. (Matt) Getz
Vice President - Human Resources
Vice President - Human Resources
34.12K
-21.64%
Mr. Andrew M. Green
Mr. Andrew M. Green
Vice President - Regulatory Affairs
Vice President - Regulatory Affairs
33.50K
-18.53%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
178.56K
-5.27%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
+4.40%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
+4.41%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
+5.12%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
125.79K
-4.06%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
121.36K
+10.09%

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Aortic stent grafts
39.84M
35.27%
On X
25.57M
22.64%
Preservation Services
25.53M
22.60%
Bio Glue
19.29M
17.07%
Surgical sealants
19.29M
17.07%
Other
2.74M
2.43%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Aortic stent grafts
39.84M
35.27%
On X
25.57M
22.64%
Preservation Services
25.53M
22.60%
Bio Glue
19.29M
17.07%
Surgical sealants
19.29M
17.07%
Other
2.74M
2.43%

Shareholding Stats

Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
11.85%
The Vanguard Group, Inc.
6.38%
Fidelity Management & Research Company LLC
6.00%
Nomura Investment Management Business Trust
5.24%
Perceptive Advisors LLC
4.26%
Other
66.27%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
11.85%
The Vanguard Group, Inc.
6.38%
Fidelity Management & Research Company LLC
6.00%
Nomura Investment Management Business Trust
5.24%
Perceptive Advisors LLC
4.26%
Other
66.27%
Shareholder Types
Shareholders
Proportion
Investment Advisor
52.10%
Investment Advisor/Hedge Fund
28.30%
Individual Investor
4.35%
Private Equity
4.26%
Hedge Fund
3.33%
Research Firm
1.87%
Pension Fund
1.05%
Bank and Trust
0.37%
Family Office
0.04%
Other
4.32%

Institutional Shareholding

Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
410
43.29M
91.25%
+30.07K
2025Q3
417
43.26M
91.49%
+621.40K
2025Q2
388
42.72M
90.85%
+749.95K
2025Q1
378
41.65M
93.88%
+1.56M
2024Q4
361
38.77M
90.20%
+1.92M
2024Q3
344
36.62M
88.99%
+563.89K
2024Q2
325
36.03M
88.04%
+491.62K
2024Q1
322
35.76M
90.55%
-2.03M
2023Q4
321
34.94M
89.27%
+12.56K
2023Q3
319
34.91M
90.03%
-219.54K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
5.54M
11.75%
-205.09K
-3.57%
Jun 30, 2025
The Vanguard Group, Inc.
2.79M
5.91%
+16.34K
+0.59%
Jun 30, 2025
Fidelity Management & Research Company LLC
2.20M
4.66%
-584.24K
-21.00%
Jun 30, 2025
Nomura Investment Management Business Trust
2.96M
6.27%
+52.54K
+1.81%
Jun 30, 2025
Perceptive Advisors LLC
2.79M
5.92%
--
--
Jun 30, 2025
Morgan Stanley Smith Barney LLC
1.93M
4.09%
-9.84K
-0.51%
Jun 30, 2025
State Street Investment Management (US)
1.51M
3.21%
-17.10K
-1.12%
Jun 30, 2025
Wellington Management Company, LLP
1.71M
3.63%
-13.99K
-0.81%
Jun 30, 2025
Juniper Investment Company, LLC
1.86M
3.95%
-229.50K
-10.96%
Aug 08, 2025
Fred Alger Management, LLC
1.35M
2.86%
+1.23M
+1018.31%
Jun 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
AAM Sawgrass US Small Cap Quality Growth ETF
4.14%
Unusual Whales Subversive Democratic Trading ETF
3.4%
ROBO Global Healthcare Technology & Innovation ETF
1.85%
State Street SPDR S&P Health Care Equipment ETF
1.74%
Invesco S&P SmallCap Health Care ETF
1.15%
Invesco Dorsey Wright Healthcare Momentum ETF
0.76%
Invesco S&P SmallCap 600 Pure Growth ETF
0.69%
First Trust Small Cap Growth AlphaDEX Fund
0.64%
Invesco Dorsey Wright SmallCap Momentum ETF
0.42%
iShares Micro-Cap ETF
0.33%
View more
AAM Sawgrass US Small Cap Quality Growth ETF
Proportion4.14%
Unusual Whales Subversive Democratic Trading ETF
Proportion3.4%
ROBO Global Healthcare Technology & Innovation ETF
Proportion1.85%
State Street SPDR S&P Health Care Equipment ETF
Proportion1.74%
Invesco S&P SmallCap Health Care ETF
Proportion1.15%
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion0.76%
Invesco S&P SmallCap 600 Pure Growth ETF
Proportion0.69%
First Trust Small Cap Growth AlphaDEX Fund
Proportion0.64%
Invesco Dorsey Wright SmallCap Momentum ETF
Proportion0.42%
iShares Micro-Cap ETF
Proportion0.33%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data

FAQs

Who are the top five shareholders of Artivion Inc?

The top five shareholders of Artivion Inc are:
BlackRock Institutional Trust Company, N.A. holds 5.54M shares, accounting for 11.75% of the total shares.
The Vanguard Group, Inc. holds 2.79M shares, accounting for 5.91% of the total shares.
Fidelity Management & Research Company LLC holds 2.20M shares, accounting for 4.66% of the total shares.
Nomura Investment Management Business Trust holds 2.96M shares, accounting for 6.27% of the total shares.
Perceptive Advisors LLC holds 2.79M shares, accounting for 5.92% of the total shares.

What are the top three shareholder types of Artivion Inc?

The top three shareholder types of Artivion Inc are:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Fidelity Management & Research Company LLC

How many institutions hold shares of Artivion Inc (AORT)?

As of 2025Q4, 410 institutions hold shares of Artivion Inc, with a combined market value of approximately 43.29M, accounting for 91.25% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.24%.

What is the biggest source of revenue for Artivion Inc?

In FY2025Q2, the Aortic stent grafts business generated the highest revenue for Artivion Inc, amounting to 39.84M and accounting for 35.27% of total revenue.
KeyAI